Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation
Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation
复制标题
寡糖-喜树碱缀合物作为潜在的抗肿瘤药物:设计、合成和生物学评价
DOI:
10.1016/j.ejmech.2020.112509
复制
发表时间:
2020-09-15
影响因子:
6.7
通讯作者:
Zhou, Wen
中科院分区:
文献类型:
--
作者:
Li, Maolin;Ye, Wenchong;Zhou, Wen
Thirty novel 20 (S)-O-linked camptothecin (CPT) glycoconjugates were synthesized. They showed more potent in vitro cytotoxicities over irinotecan, but very weak direct topoisomerase I (Topo I) inhibition was observed at 100.0 mu M. Oligosaccharide types, length of a PEG linker and acetyl groups exerted obvious effects on cytotoxicity, selectivity, water solubility and stability of the newly synthesized CPT glyco-conjugates. Construct 40, with a bleomycin (BLM) disaccharide linked to diethylene glycol in the introduced ester moiety, demonstrated a superior antitumor activity and a distinct selectivity compared to CPT. No toxicity was detectable in animal acute toxicity intravenously (160 mg/kg). Collectively, attachment of oligosaccharides with tumor targeting to 20 (S)-OH of CPT could offer a solution to the daunting problems posed by current Topo I poisons. (C) 2020 Elsevier Masson SAS. All rights reserved.